Zobrazeno 1 - 10
of 329
pro vyhledávání: ''
Autor:
Samuli Tuominen, Kristiina Uusi-Rauva, Tea Blom, Sirkku Jyrkkiö, Kaisa Tuppurainen, Erika Alanne
Publikováno v:
Future Oncology. 18:1103-1114
Background: Real-world data on diffuse large B-cell lymphoma (DLBCL) has remained incomplete. In Finland, health record data originally recorded in different hospital data record systems are collectively available via data lake technology, enabling e
Publikováno v:
Future Oncology. 18:859-870
Objectives: To evaluate the cost–effectiveness of immune checkpoint inhibitors versus docetaxel in patients with advanced non-small-cell lung cancer. Methods: A Markov model was constructed to simulate the clinical outcomes and costs of advanced no
Autor:
Zhouwei Zhan, Xiaojie Wang, Jiami Yu, Jingxian Zheng, Yi Zeng, Mingyao Sun, Li Peng, Zengqing Guo, Bijuan Chen
Publikováno v:
Future Oncology. 18:1259-1271
Objective: To investigate the efficacy and safety of intraperitoneal administration of recombinant human endostatin in gastric cancer with malignant ascites. Methods: Clinical data of 90 patients (37 in an Endostar® combined with cisplatin group and
Autor:
Andrea Leith, Amanda Ribbands, Jeri Kim, Matthew Last, Sophie Barlow, Lingfeng Yang, Sameer R Ghate
Publikováno v:
Future Oncology. 18:937-951
Aim: To assess homologous recombination repair mutation (HRRm) testing patterns in metastatic castration-resistant prostate cancer. Methods: A point-in-time, international survey conducted January–August 2020. Results: Three-quarters of physicians
Publikováno v:
Future Oncology. 18:1273-1284
Aim: To investigate the association between receiving treatment at academic centers and overall survival in pancreatic ductal adenocarcinoma patients who do not receive definitive surgery of the pancreatic tumor. Methods: Using the National Cancer Da
Publikováno v:
Future Oncology. 18:927-936
Aim: To characterize real-world patterns of second-line treatment and outcomes in older patients with advanced/metastatic esophageal squamous cell carcinoma (ESCC). Patients and methods: Patients aged ≥66 years diagnosed with advanced/metastatic ES
Autor:
Kathryn Tremble, Louis Fox, Charlotte Moss, Beth Russell, Haleema Aljazzaf, Finola Higgins, Bill Dann, Vikash Jogia, Graham Roberts, Anne Rigg, Saoirse Dolly, Mieke Van Hemelrijck
Publikováno v:
Future Oncology
Objective: The authors monitored positivity rates of asymptomatic SARS-CoV-2 tests during the second wave of COVID-19 at Guy's Cancer Centre. Methods: Logistic regression was used to investigate factors associated with asymptomatic COVID positivity r
Autor:
Laura Sellmer, Julia Kovács, Jens Neumann, Julia Walter, Diego Kauffmann-Guerrero, Zulfiya Syunyaeva, Jan Fertmann, Christian Schneider, Julia Zimmermann, Juergen Behr, Amanda Tufman
Publikováno v:
Future Oncology. 18:481-489
Aim: To analyze immune cell populations in non-small-cell lung cancer (NSCLC) tumors and matched tumor-bearing and non-tumor-bearing lymph nodes (ntbLNs) to predict prognosis. Patients & methods: 71 patients with long-term disease-free survival and 8
Publikováno v:
Future Oncology. 18:679-690
Objective: D-dimer is correlated to the poor prognosis of non-small-cell lung cancer. The study aimed to investigate the association between plasma D-dimer and concomitant mutations in non-small-cell lung cancer. Methods: A total of 517 non-small-cel
Publikováno v:
Future Oncology
Introduction: The objective of this study was to evaluate the clinical and laboratory outcomes of solid cancer patients who were reinfected with COVID-19. Methods: Patients who were tested negative on the Coronavirus disease 2019 (COVID-19) PCR test